Overview

Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution

Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized trial comparing two elution doses of the Travoprost Intraocular implant to timolol ophthalmic solution.
Phase:
Phase 2
Details
Lead Sponsor:
Glaukos Corporation
Treatments:
Maleic acid
Ophthalmic Solutions
Pharmaceutical Solutions
Timolol
Travoprost